Whalesbook
Aise kaise bhaga share?
Asal mein, company ne apna strategy change kiya hai. Ab lower-margin government contracts ki jagah high-margin private Panchakarma treatments aur product sales par zyada focus kar rahe hain. Isi wajah se growth pakdi hai.
Numbers kya bolte hain? (Financials)
Company ne results mein kamaal kar diya hai! Pichhle 3 saalon mein revenue 71% CAGR se badha hai FY25 tak. Profitability bhi mast improve hui hai. FY26 ke pehle 9 mahine mein operating margins 46.4% tak pahunch gaye, jo FY25 mein sirf 27% the. Aur net profit margins toh 30.2% ho gaye hain!
Operations aur Expansion ka game!
Company ka operations bhi bahut efficient hai. Ek bed se hone wali average earning (ARPOB) Rs 6,100 (FY23) se badh kar ab Rs 8,300 se upar chali gayi hai. Ye log bahut kam paisa laga kar facilities expand kar rahe hain, jahan chote centers bhi jaldi recover ho jaate hain. Bed capacity FY23 mein 460 thi, jo ab Q3 FY26 tak 2,800 ho gayi hai. Target hai 3-5 saal mein 7,000 se 10,000 beds tak pahunchna. Is wajah se return on capital employed bhi 58% ke aas paas hai.
Kya hain Risks?
Lekin bhai, kuch cheezein dhyan rakhni hongi. Itna bada expansion plan, 2,800 se 7,000-10,000 beds tak jaana, sahi se execute karna hoga. Ayurveda par depend karna aur government regulations change hona bhi ek risk hai. Agar jaldi growth ke chakkar mein paise atak gaye toh working capital mein problem aa sakti hai. Aur competition toh hai hi.